Loading...

Yafei Hou, MD, PhD

TitleAssociate Researcher
InstitutionUniversity of California San Francisco
DepartmentVice Chanc Research
Phone415-514-3160
vCardDownload vCard

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chheda ZS, Kohanbash G, Okada K, Jahan N, Sidney J, Pecoraro M, Yang X, Carrera DA, Downey KM, Shrivastav S, Liu S, Lin Y, Lagisetti C, Chuntova P, Watchmaker PB, Mueller S, Pollack IF, Rajalingam R, Carcaboso AM, Mann M, Sette A, Garcia KC, Hou Y, Okada H. Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med. 2018 Jan 02; 215(1):141-157. PMID: 29203539.
      View in: PubMed
    2. Hou Y, Wang K, Xiao K, Qin W, Lu W, Tao W, Cui D. Smartphone-Based Dual-Modality Imaging System for Quantitative Detection of Color or Fluorescent Lateral Flow Immunochromatographic Strips. Nanoscale Res Lett. 2017 Dec; 12(1):291. PMID: 28438012.
      View in: PubMed
    3. Lu W, Wang K, Xiao K, Qin W, Hou Y, Xu H, Yan X, Chen Y, Cui D, He J. Dual Immunomagnetic Nanobeads-Based Lateral Flow Test Strip for Simultaneous Quantitative Detection of Carcinoembryonic Antigen and Neuron Specific Enolase. Sci Rep. 2017 Feb 10; 7:42414. PMID: 28186176.
      View in: PubMed
    4. Xiao K, Wang K, Qin W, Hou Y, Lu W, Xu H, Wo Y, Cui D. Use of quantum dot beads-labeled monoclonal antibody to improve the sensitivity of a quantitative and simultaneous immunochromatographic assay for neuron specific enolase and carcinoembryonic antigen. Talanta. 2017 Mar 01; 164:463-469. PMID: 28107959.
      View in: PubMed
    5. Qin W, Wang K, Xiao K, Hou Y, Lu W, Xu H, Wo Y, Feng S, Cui D. Carcinoembryonic antigen detection with "Handing"-controlled fluorescence spectroscopy using a color matrix for point-of-care applications. Biosens Bioelectron. 2017 Apr 15; 90:508-515. PMID: 27825889.
      View in: PubMed
    6. Cha E, Klinger M, Hou Y, Cummings C, Ribas A, Faham M, Fong L. Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients. Sci Transl Med. 2014 May 28; 6(238):238ra70. PMID: 24871131; PMCID: PMC4558099.
    7. Khan IS, Mouchess ML, Zhu ML, Conley B, Fasano KJ, Hou Y, Fong L, Su MA, Anderson MS. Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance. J Exp Med. 2014 May 05; 211(5):761-8. PMID: 24752296; PMCID: PMC4010907.
    8. Kwek SS, Dao V, Roy R, Hou Y, Alajajian D, Simko JP, Small EJ, Fong L. Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients. J Immunol. 2012 Oct 01; 189(7):3759-66. PMID: 22956585; PMCID: PMC3448828.
    9. DeVoss JJ, LeClair NP, Hou Y, Grewal NK, Johannes KP, Lu W, Yang T, Meagher C, Fong L, Strauss EC, Anderson MS. An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse. J Immunol. 2010 Apr 15; 184(8):4236-46. PMID: 20237294; PMCID: PMC2851482.
    10. Shum AK, DeVoss J, Tan CL, Hou Y, Johannes K, O'Gorman CS, Jones KD, Sochett EB, Fong L, Anderson MS. Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance. Sci Transl Med. 2009 Dec 02; 1(9):9ra20. PMID: 20368189; PMCID: PMC2856693.
    11. Hou Y, DeVoss J, Dao V, Kwek S, Simko JP, McNeel DG, Anderson MS, Fong L. An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans. J Clin Invest. 2009 Jul; 119(7):2031-41. PMID: 19603556; PMCID: PMC2701875.
    12. Kavanagh B, O'Brien S, Lee D, Hou Y, Weinberg V, Rini B, Allison JP, Small EJ, Fong L. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion. Blood. 2008 Aug 15; 112(4):1175-83. PMID: 18523152; PMCID: PMC2515138.
    13. Fassò M, Waitz R, Hou Y, Rim T, Greenberg NM, Shastri N, Fong L, Allison JP. SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade. Proc Natl Acad Sci U S A. 2008 Mar 04; 105(9):3509-14. PMID: 18303116; PMCID: PMC2265147.
    14. Hou Y, Kavanagh B, Fong L. Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen. J Immunol. 2008 Feb 01; 180(3):1526-34. PMID: 18209048.
      View in: PubMed
    15. DeVoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J, Chang H, Caspi RR, Caspi R, Fong L, Anderson MS. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med. 2006 Nov 27; 203(12):2727-35. PMID: 17116738; PMCID: PMC2118158.
    16. Fong L, Hou Y, Rivas A, Benike C, Yuen A, Fisher GA, Davis MM, Engleman EG. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A. 2001 Jul 17; 98(15):8809-14. PMID: 11427731; PMCID: PMC37517.
    17. Hou Y, Sun ZT. Qu CF., Appella E., Harris CC. .Effect of HLA -A2 subtype on the CTL responses induced by the dendritic cells that are generated from human umbilical cord blood. Chin J Microbiol Immunol. 1999; 1(19):47.